ClinicalTrials.gg
CompletedNCT06365476Updated Nov 18, 2026

FlexWave Trial: Efficacy of Extracorporeal Shock Wave Therapy in Post-Stroke Upper Limb Spasticity

An interventional study of focused extracorporeal shock wave therapy (ESWT) in Stroke and Spasticity, Muscle, sponsored by National Taiwan University Hospital. Completed at 1 site in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

How we know

Updated Nov 18, 2026Now CompletedNow Active, not recruiting+8 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 77 studies in Stroke by National Taiwan University Hospital — 21 open to participants now, 22 under way, none of them phase 3. Stroke · National Taiwan University Hospital.

Enrollment
36th of 52
40 · median 70
Started
2024
with 5 others
No phase
43 of 77
17 open now
Registered
67th of 77
by date

Among the 77 studies in Stroke by National Taiwan University Hospital, this one is the 36th largest by enrollment of the 52 interventional ones that give a count, is one of 6 that started in 2024, is one of 43 with no phase, and was the 67th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

21 of the 77 studies in Stroke by National Taiwan University Hospital are open now, in 1 country. Recruiting first, the newest first:

16 more — sign in →

By country, each count listing its studies:

All 21 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 77 studies in Stroke by National Taiwan University Hospital, or all of them as a file.
02

Study summary

Extracorporeal shock wave therapy (ESWT) has emerged as an effective therapeutic intervention for addressing post-stroke limb spasticity. This research aims to explore the therapeutic implications of focused ESWT for wrist and finger flexor muscles in patients suffering from post-stroke upper limb spasticity.

Read the detailed description

This study aimed to evaluate the effects of focused Extracorporeal Shock Wave Therapy (ESWT) on upper limb flexor spasticity in stroke patients. Participants were randomized into two groups: an experimental group receiving targeted ESWT on specific forearm flexor muscles, and a control group receiving placebo treatments mimicking the shockwave therapy, with treatments administered twice weekly over two weeks for a total of four sessions.

The efficacy of the treatment was measured using a comprehensive set of assessment tools, including range of motion, hand grip strength, pain levels, spasticity scales, functional assessments, as well as measures of daily living activities, ultrasound strain elastography. The outcomes were evaluated at multiple points in time: before treatment, and 1, 4, 12, and 24 weeks after the therapy concluded, to assess both immediate and sustained effects of the treatment on upper limb function and spasticity in stroke survivors.

03

Conditions studied

  • Stroke
  • Spasticity, Muscle

Keywords

  • stroke
  • spasticity
  • shock wave
  • wrist
  • finger
04

Who can participate

The criteria were revised on the registry on Nov 18, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals aged 18 years or older with unilateral cerebral stroke.
  • Wrist/finger flexor muscle tone with a score greater than 1 on the Modified Ashworth Scale.
  • Stable medical condition and vital signs.
  • Conscious and able to comply with instructions.

Exclusion criteria

Exclusion Criteria:

  • History of more than one stroke, traumatic brain injury, or cerebral neoplasm.
  • Coexisting central nervous system disorders (e.g., spinal cord injury, Parkinson's disease) or other musculoskeletal diseases affecting muscle tone assessment.
  • for shockwave intervention, such as , coagulopathies, local infections, or use of cardiac pacemakers.
  • Undergone shockwave therapy or botulinum toxin injections for post-stroke spasticity in the past three months.
  • Cognitive, consciousness, or language impairments preventing participation in the intervention or functional assessments.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Focused Extracorporeal Shock Wave Therapy

    Participants in this arm will receive focused Extracorporeal Shock Wave Therapy (ESWT) targeting three specific muscles: the flexor carpi ulnaris, flexor carpi radialis, and flexor digitorum superficialis. Each muscle will receive 1,500 shockwave shots per session, accumulating to a total of 4,500 shots across all targeted muscles in each session. The treatment will be administered twice a week for two consecutive weeks, resulting in a total of four treatment sessions.

    Device: focused extracorporeal shock wave therapy (ESWT)

  • Placebo comparator
    Placebo-Controlled Shockwave Therapy

    Participants in this arm will receive placebo-controlled focused ESWT, mirroring the treatment protocol of the experimental group but without the application of active shockwaves.

    Device: focused extracorporeal shock wave therapy (ESWT)

Interventions

  • Devicefocused extracorporeal shock wave therapy (ESWT)

    The focused shockwaves are directed at the affected muscles in the upper limb, specifically targeting the flexor carpi ulnaris, flexor carpi radialis, and flexor digitorum superficialis.

06

What researchers measure

Primary outcomes

  1. modified Ashworth scale (MAS)

    Evaluate spasticity in individuals with neurological conditions. The scale ranges from 0, indicating no increase in muscle tone, to 4, which represents severe spasticity with affected parts rigid in flexion or extension.

    Time frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment

Secondary outcomes

  1. modified Tardieu scale (MTS) R2-R1 Angle

    Difference between passive range of motion (R2) and the angle of muscle catch (R1), measured in degrees. Larger values indicate greater dynamic spasticity.

    Time frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment

  2. Tardieu grade

    Spasticity severity (0-5); higher grades indicate greater spasticity.

    Time frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment

  3. passive range of motion for the wrist and finger joints

    the extent to which a joint can be moved without the patient actively participating in the movement

    Time frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment

  4. Medical Research Council (MRC) scale

    grades voluntary muscle strength on a 0-5 ordinal scale

    Time frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment

  5. hand grip strength

    use dynamometer to record the maximum force applied when the patient squeezes it

    Time frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment

  6. Barthel index

    measures a person's daily living abilities, focusing on ten areas of self-care and mobility. Scores range from 0 to 100, with higher scores denoting greater independence.

    Time frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment

  7. Functional Independence Measure (FIM)

    assesses a patient's level of disability and tracks changes over time, with a focus on physical and cognitive functioning across 18 items, scored from 18 (total assistance required) to 126 (fully independent).

    Time frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment

  8. Wolf Motor Function Test (WMFT) Functional ability score

    assess upper extremity function in individuals with neurological impairments, using 15 functional tasks. Scoring is on a 6-point ordinal scale, ranging from 0 ("Does not attempt with upper extremity being tested," indicating severe impairment) to 5 ("Movement appears to be normal," suggesting full functionality). Lower scores indicate greater impairment.

    Time frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment

  9. Action Research Arm Test (ARAT)

    a standardized measure evaluating upper limb motor ability in stroke patients, scoring from 0 (no movement) to 57 (normal arm function). It assesses grasp, grip, pinch, and gross arm movement.

    Time frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment

  10. Fugl-Meyer Assessment for the Upper Extremity (FMA-UE)

    range from 0 (complete paralysis) to 66 (full function), assessing motor recovery in post-stroke upper extremities

    Time frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment

  11. ultrasound assessment

    used strain elastography to assess elasticity of forearm muscles

    Time frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment

07

Study locations

1 site
08

References and documents

Publications

  • Dymarek R, Taradaj J, Rosinczuk J. Extracorporeal Shock Wave Stimulation as Alternative Treatment Modality for Wrist and Fingers Spasticity in Poststroke Patients: A Prospective, Open-Label, Preliminary Clinical Trial. Evid Based Complement Alternat Med. 2016;2016:4648101. doi: 10.1155/2016/4648101. Epub 2016 Jul 18. PubMed 27504139 ↗
  • Cabanas-Valdes R, Calvo-Sanz J, Urrutia G, Serra-Llobet P, Perez-Bellmunt A, German-Romero A. The effectiveness of extracorporeal shock wave therapy to reduce lower limb spasticity in stroke patients: a systematic review and meta-analysis. Top Stroke Rehabil. 2020 Mar;27(2):137-157. doi: 10.1080/10749357.2019.1654242. Epub 2019 Nov 11. PubMed 31710277 ↗
  • Yasar E, Adiguzel E, Kesikburun S, Yenihayat I, Yilmaz B, Alaca R, Tan AK. Assessment of forearm muscle spasticity with sonoelastography in patients with stroke. Br J Radiol. 2016 Dec;89(1068):20160603. doi: 10.1259/bjr.20160603. Epub 2016 Oct 25. PubMed 27679870 ↗
  • Jia G, Ma J, Wang S, Wu D, Tan B, Yin Y, Jia L, Cheng L. Long-term Effects of Extracorporeal Shock Wave Therapy on Poststroke Spasticity: A Meta-analysis of Randomized Controlled Trials. J Stroke Cerebrovasc Dis. 2020 Mar;29(3):104591. doi: 10.1016/j.jstrokecerebrovasdis.2019.104591. Epub 2019 Dec 31. PubMed 31899073 ↗

Individual participant data

Plan to share: No

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2024 to primary completion in Jul 2026, 27 months.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 27 months is above that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

Primary completion moved twice since we started tracking on Sep 25, 2026: Apr 2026 → Jul 2026, last on Nov 18, 2026.

Completion moved twice since we started tracking on Sep 25, 2026: Apr 2027 → Jul 2026, last on Nov 18, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 9, 2024
First posted
Apr 15, 2024
StartActual
Apr 13, 2024
Primary completionActual
Jul 31, 2026was Apr 2026
CompletionActual
Jul 31, 2026was Apr 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Active, not recruiting→Completed
changed Oct 20, 2026 · changed Nov 18, 2026
Sites
1 site added, 1 site removed
Show site
  • Department of Physical Medicine & Rehabilitation , National Taiwan University Hospital · Taipei, Taiwan
Show 1 removed
  • Department of Physical Medicine & Rehabilitation , National Taiwan University Hospital · Taipei, Taiwan
Nov 18, 2026
Start date
Apr 15, 2024→Apr 13, 2024
moved 2 times, Oct 20, 2026 – Nov 18, 2026
Primary completion
Apr 15, 2026→Jul 31, 2026 (actual)
moved 2 times, Oct 20, 2026 – Nov 18, 2026
Study completion
Apr 15, 2027→Jul 31, 2026 (actual)
moved 2 times, Oct 20, 2026 – Nov 18, 2026
Eligibility
1 inclusion criterion edited
What changed in the criteria
Inclusion criteria
  • EditedWrist and /finger flexor muscle tone with a score greater than 1 on the Modified Ashworth Scale.
Nov 18, 2026
Primary outcomes
4 removed
What changed in the outcomes
  • Removedpassive range of motion for the wrist and finger jointsTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
  • Removedhand grip strengthTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
  • RemovedVisual Analogue Scale (VAS)Time frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
  • Removedmodified Tardieu scale (MTS)Time frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
Oct 20, 2026
Secondary outcomes
1 edited, 5 added, 1 removed
What changed in the outcomes
  • EditedWolf Motor Function Test (WMFT) Functional ability scoreTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
  • Addedmodified Tardieu scale (MTS) R2-R1 AngleTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
  • AddedTardieu gradeTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
  • Addedpassive range of motion for the wrist and finger jointsTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
  • AddedMedical Research Council (MRC) scaleTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
  • Addedhand grip strengthTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
  • RemovedBox and Block TestTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
Oct 20, 2026
Show all 2 updates
  1. Nov 18, 2026
    Active, not recruiting→Completed
    1 site added, 1 site removed
    Show site
    • Department of Physical Medicine & Rehabilitation , National Taiwan University Hospital · Taipei, Taiwan
    Show 1 removed
    • Department of Physical Medicine & Rehabilitation , National Taiwan University Hospital · Taipei, Taiwan
    Start date Mar 22, 2024→Apr 13, 2024
    Primary completion Oct 31, 2026→Jul 31, 2026 (now actual)
    Study completion Oct 31, 2026→Jul 31, 2026 (now actual)
    Eligibility 1 inclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • EditedWrist and /finger flexor muscle tone with a score greater than 1 on the Modified Ashworth Scale.
  2. Oct 20, 2026
    Recruiting→Active, not recruiting
    Start date Apr 15, 2024→Mar 22, 2024
    Primary completion Apr 15, 2026→Oct 31, 2026
    Study completion Apr 15, 2027→Oct 31, 2026
    Primary outcomes 4 removed
    What changed in the outcomes
    • Removedpassive range of motion for the wrist and finger jointsTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
    • Removedhand grip strengthTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
    • RemovedVisual Analogue Scale (VAS)Time frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
    • Removedmodified Tardieu scale (MTS)Time frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
    Secondary outcomes 1 edited, 5 added, 1 removed
    What changed in the outcomes
    • EditedWolf Motor Function Test (WMFT) Functional ability scoreTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
    • Addedmodified Tardieu scale (MTS) R2-R1 AngleTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
    • AddedTardieu gradeTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
    • Addedpassive range of motion for the wrist and finger jointsTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
    • AddedMedical Research Council (MRC) scaleTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
    • Addedhand grip strengthTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
    • RemovedBox and Block TestTime frame: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
    + 5 other changes: verification date, description, contact details, site details and references

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06365476
Responsible party
Sponsor
First posted
Apr 15, 2024
Start date
Apr 13, 2024
Primary completion
Jul 31, 2026
Completion
Jul 31, 2026
Last update
Nov 18, 2026

Study contacts

Shu-mei Yang, MD
principal investigator · National Taiwan University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion